Literature DB >> 29286872

Drug-induced immune thrombocytopenia: Mapping of the drug binding site to the membrane-proximal region of platelet GPIX.

Zohra Ahmadi1, Jose Perdomo2, Rose Wong1, Beng H Chong2,1.   

Abstract

Drug-induced Immune thrombocytopenia (DIT) is a common complication of several medications, including commonly used antibiotics. The most widely studied DIT is caused by quinine. In DIT, antibodies predominantly bind to the platelet membrane glycoprotein (GP) IX in a drug-dependent fashion resulting in increased platelet clearance. Binding of the sensitizing drug, such as quinine, to GPIX has been proposed but is yet to be established. This work demonstrates that quinine is retained specifically by human GPIX. Quinine binding was first analyzed in wild-type mouse platelets and in transgenic mouse platelet expressing human GPIX using high performance liquid chromatography. Binding of quinine to GPIX was then measured in Chinese hamster ovary (CHO) cells expressing a combination of wild type, human or mouse, three human/mouse chimeric constructs and six mutant GPIX proteins. Quinine was retained by human GPIX. No detectable absorption was observed with mouse GPIX or human GPIbα. The quinine binding site was mapped to residues 110-115 of human GPIX suggesting that quinine interacts with specific residues of the GP. These findings provide further insights into the molecular mechanisms of DIT.

Entities:  

Keywords:  Drug-induced thrombocytopenia; QITP; glycoprotein IX; platelets; quinine

Mesh:

Substances:

Year:  2017        PMID: 29286872     DOI: 10.1080/09537104.2017.1419556

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  1 in total

1.  Acute drug-induced immune thrombocytopenia - A work of articaine.

Authors:  Ingvild Jenssen Laegreid; Mats Irgen Olsen; Jon Inge Harr; Renathe Henriksen Grønli; Trude Victoria Mørtberg; Siw Leiknes Ernstsen; Maria Therese Ahlen
Journal:  Transfusion       Date:  2022-03-19       Impact factor: 3.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.